RxDoctor Payments Data

Lauren Sandmann-Crow, PA

Physician Assistant · Ada, OKNPI 1689052953

Payments from drug & device makers

$667in general payments, 2019–2025

Across 38 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$270
  • Lilly USA, LLC$111
  • AbbVie$101
  • Takeda Pharmaceuticals U.S.A., Inc.$60
  • Vanda Pharmaceuticals Inc.$29
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$25
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$667100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$667 in reported general payments places this provider in the 65th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$12,556
Medicare patients
99
Services billed
131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide22$35,118
OzempicSemaglutide16$15,525
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,228
TrulicityDulaglutide14$13,236
Testosterone Cypionate17$853
Omeprazole40$727
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$585
Albuterol Sulfate HfaAlbuterol Sulfate18$467
Gabapentin22$432
Pravastatin Sodium25$376
Fenofibrate19$374
Levothyroxine Sodium34$342
Ondansetron Hcl24$304
Liothyronine Sodium11$286
Celecoxib16$267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$111$48,35436 claims
Novo NordiskOzempic$270$15,52516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Ada

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →